RxSight, Inc. (RXST)

NASDAQ: RXST · IEX Real-Time Price · USD
16.40
-0.27 (-1.62%)
Mar 27, 2023, 4:00 PM EDT - Market closed

Cash Flow Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019
Net Income
-66.76-48.693.3726.13
Depreciation & Amortization
4.023.994.013.93
Share-Based Compensation
11.47.584.194.6
Other Operating Activities
-7.51-7.58-70.98-175.37
Operating Cash Flow
-58.85-44.71-35.2-40.62
Capital Expenditures
-2.39-1.94-2.54-3.48
Change in Investments
42.34-79.9718.13-2.39
Investing Cash Flow
39.95-81.9115.59-5.87
Share Issuance / Repurchase
7.83121.140.991.52
Debt Issued / Paid
-0.2714.8424.17-0.19
Other Financing Activities
-1.231.370.07-
Financing Cash Flow
6.33137.3425.241.33
Net Cash Flow
-12.5810.725.63-45.15
Free Cash Flow
-61.24-46.65-37.74-44.1
Free Cash Flow Margin
-124.97%-206.47%-257.11%-1967.96%
Free Cash Flow Per Share
-2.21-3.42-10.18-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).